CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion

[1]  S. Rosenberg,et al.  Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: Analysis by cytokine secretion , 2005, Cancer Immunology, Immunotherapy.

[2]  B. Hazaz,et al.  Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer , 2004, Cancer Immunology, Immunotherapy.

[3]  S. Rosenberg,et al.  Melanoma‐specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by epstein‐barr virus‐transformed B cells , 1994, International journal of cancer.

[4]  T. Eberlein,et al.  HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer. , 1993, Journal of immunology.

[5]  P. Tak,et al.  A Subset of Vδ1+ T Cells Proliferates in Response to Epstein‐Barr Virus‐Transformed B Cell Lines In Vitro , 1993 .

[6]  S. Rosenberg,et al.  Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha in response to autologous tumor stimulation. , 1993, Blood.

[7]  P. Chomez,et al.  Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. , 1992, International journal of cancer.

[8]  S. Rosenberg,et al.  Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion. , 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

[9]  S. Rosenberg,et al.  Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. , 1992, Journal of immunology.

[10]  A. Rubbert,et al.  Functional characterization of tumor‐infiltrating lymphocytes, lymph‐node lymphocytes and peripheral‐blood lymphocytes from patients with breast cancer , 1991, International journal of cancer.

[11]  S. Rosenberg,et al.  Common Expression of Melanoma Tumor-Associated Antigens Recognized by Human Tumor Infiltrating Lymphocytes: Analysis by Human Lymphocyte Antigen Restriction , 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

[12]  P. Stastny,et al.  DNA typing for class II HLA antigens with allele-specific or group-specific amplification. IV. Typing for alleles of the HLA-DR2 group. , 1991, Human immunology.

[13]  S. Rosenberg,et al.  Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation. , 1991, Journal of immunology.

[14]  R. Rees,et al.  Factors influencing the establishment of tumour-infiltrating lymphocyte cultures from human breast carcinoma and colon carcinoma tissue. , 1991, European journal of cancer.

[15]  E. Mallon,et al.  Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. , 1990, British Journal of Cancer.

[16]  S. Rosenberg,et al.  Separation and growth of human CD4+ and CD8+ tumor-infiltrating lymphocytes and peripheral blood mononuclear cells by direct positive panning on covalently attached monoclonal antibody-coated flasks. , 1990, Journal of biological response modifiers.

[17]  J. Yewdell,et al.  The binary logic of antigen processing and presentation to T cells , 1990, Cell.

[18]  P. Cresswell,et al.  Intracellular transport and peptide binding properties of HLA class II glycoproteins. , 1990, Seminars in immunology.

[19]  C. Balch,et al.  Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. , 1990, Archives of surgery.

[20]  J. Yannelli,et al.  Activation and expansion of tumor-derived activated cells for therapeutic use. , 1989, Journal of the National Cancer Institute.

[21]  S. Rosenberg,et al.  Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. , 1989, Journal of immunology.

[22]  S. Rosenberg,et al.  Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. , 1987, Journal of immunological methods.

[23]  R. Walker,et al.  Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast , 1987, The Journal of pathology.

[24]  R. Germain.  Immunology: The ins and outs of antigen processing and presentations , 1986, Nature.

[25]  G. Klein,et al.  Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones. , 1986, Cellular immunology.

[26]  S. Miescher,et al.  Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. , 1986, Journal of immunology.

[27]  J. Sloane,et al.  An immunohistological study of leukocyte localization in benign and malignant breast tissue , 1985, International journal of cancer.

[28]  P. Beverley,et al.  Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens. , 1984, British Journal of Cancer.

[29]  O. Eremin,et al.  Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity. , 1981, British Journal of Cancer.

[30]  M. Moore,et al.  Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours , 1979, International journal of cancer.